Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 8.635.795.754.703.37

What is the latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS is 8.63 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20248.63
Mar20235.79
Mar20225.75
Mar20214.70
Mar20203.37

How is EV/Core EBITDA of LINCOLN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 8.63
49.05
Mar2023 5.79
0.70
Mar2022 5.75
22.34
Mar2021 4.7
39.47
Mar2020 3.37 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,127.8 Cr -4.2% -6.4% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,254.0 Cr -2.3% -3.5% 9.2% Stock Analytics
DIVIS LABORATORIES ₹172,374.0 Cr -2.8% 1.3% 42.3% Stock Analytics
CIPLA ₹119,795.0 Cr -0.3% 3% -2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,698.0 Cr -3.7% 7.2% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,218.0 Cr -1% -0.5% 13.2% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-4.2%

-6.4%

-8.1%

SENSEX

-0.4%

0.2%

5.9%


You may also like the below Video Courses